Autres langues Shanghai Rendu Biotechnology Co., Ltd.

Actions

688193

CNE1000059K5

Equipement, fournitures et distribution médicale

Cours en clôture Shanghai S.E. 21/09/2026			Varia. 5j.	Varia. 1 janv.
46,79 ^CNY	+2,72%		+3,86%	-3,27%

28/08	Shanghai Rendu Biotechnology Co., Ltd. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
14/05	Shanghai Rendu Biotechnology : reprise de la cotation le 15 mai	RE

Autres langues

28/08	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
14/05	Shanghai Rendu Biotechnology's share trade to resume from May 15
14/05	Nanjing Haijing Pharmaceutical Co., Ltd. agreed to acquire 21.25% stake in Shanghai Rendu Biotechnology Co., Ltd. from Ju Jinliang, Qiming Weichuang Venture Capital Management Company Limited, Runcong Enterprise Management Center (Limited Partnership), China International Capital Corporation Limited, Qiming Ventures Fund III, Changzhou Jinxin Venture Capital Co., Ltd. and Novel Praise Limited for approximately CNY 520 million.
08/05	Rendu Biotech's Controlling Shareholder Eyes Share Transfer Deal
07/05	Trading in Shanghai Rendu Biotechnology's shares to halt
28/04	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
27/02	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
30/10/25	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
29/08/25	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
29/04/25	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
27/02/25	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
29/10/24	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
29/08/24	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
20/08/24	Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
16/08/24	Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback announced on February 19, 2024, has closed with 1,291,428 shares, representing 3.23% for CNY 35.65 million.
02/07/24	Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
29/04/24	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
02/04/24	Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
27/02/24	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
19/02/24	Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
18/02/24	Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.
30/10/23	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
31/07/23	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
21/06/23	Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit
25/04/23	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023